A detailed history of Planning Capital Management Corp transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Planning Capital Management Corp holds 1,100 shares of CORT stock, worth $63,294. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,100
Previous 3,100 64.52%
Holding current value
$63,294
Previous $101 Million 49.46%
% of portfolio
0.03%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$29.51 - $46.26 $59,020 - $92,520
-2,000 Reduced 64.52%
1,100 $50.9 Million
Q4 2023

Feb 14, 2024

BUY
$24.82 - $32.88 $76,942 - $101,928
3,100 New
3,100 $101 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.16B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.